Welcome to our dedicated page for Nature’S Sun news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature’S Sun stock.
Nature’s Sunshine Products, Inc. (NASDAQ: NATR) is a natural health and wellness company that manufactures and distributes herbal, nutritional and personal care products in more than 40 countries. As a public company listed on the Nasdaq Capital Market, it regularly releases news that covers product innovation, regional performance, capital markets activity and leadership changes.
Investors and observers following NATR news can expect updates on financial results, including quarterly net sales by segment across Asia, Europe, North America and Latin America & Other, along with commentary on gross margins, adjusted EBITDA and the impact of foreign currency. Earnings releases are typically accompanied by conference call announcements where management discusses business trends, digital initiatives and regional performance.
Nature’s Sunshine also issues news on product launches and relaunches. Recent examples include the relaunch of its Power Line suite of metabolic health supplements—Power Beets, Power Greens, Power Meal and Power Balance—and recognition of Synergy WorldWide’s flagship product Pro-Argi-9+ as the world’s #1 L-arginine supplement in its category, based on Euromonitor International research.
Corporate governance and leadership developments feature prominently in NATR news, such as the appointment of a new Chief Executive Officer and senior supply chain leadership. In addition, the company reports on capital markets transactions, including secondary public offerings by major stockholders and related share repurchase agreements, as well as updates on joint venture arrangements and ownership changes in key international operations.
This news page aggregates these disclosures so readers can track Nature’s Sunshine’s financial performance, product pipeline, strategic initiatives and governance developments over time. For those researching NATR stock or the broader natural health and wellness space, the news flow provides context on how the company manages growth, regulatory complexity, supply chain operations and its global consultant and customer base.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on May 6, 2021, at 5:00 p.m. Eastern time to discuss its financial results for Q1 2021, ending March 31, 2021. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which includes a Q&A session. Investors can join the call by dialing the provided numbers and are encouraged to register 5-10 minutes before the start. A replay will be accessible following the call through May 20, 2021. For more information, please visit Nature’s Sunshine website.
Nature’s Sunshine Products (Nasdaq: NATR) reported a powerful fourth quarter for 2020, achieving record net sales of $101.7 million, a 11% increase from the previous year. GAAP net income soared 445% to $6.7 million, equivalent to $0.29 per diluted share. The company declared a special cash dividend of $1.00 per share and announced a $15 million share repurchase program. Full-year sales reached $385.2 million, marking a 6% increase from 2019. Despite increased SG&A expenses, the firm continues to prioritize financial stability and future growth initiatives.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on March 10, 2021, at 5:00 p.m. Eastern time to discuss its fourth-quarter and full-year financial results for 2020. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which includes a Q&A session. Participants can join the call using the provided toll-free and international dial-in numbers. A replay will be available until March 24, 2021. Nature’s Sunshine operates in over 40 countries, manufacturing high-quality nutritional and personal care products.
Nature’s Sunshine Products (Nasdaq: NATR) announced a record net sales of $100.3 million for the third quarter of 2020, marking a 13% increase from the previous year. GAAP net income rose significantly to $7.2 million or $0.34 per diluted share. Adjusted EBITDA also increased by 13% to $9.4 million.
The growth was fueled by robust consumer demand, new product launches, and easing COVID-19 restrictions in key markets, particularly in U.S. and China. The company aims to further enhance customer engagement and support distributors as part of its business transformation initiatives.
Nature’s Sunshine Products (NASDAQ: NATR) will hold a conference call on November 9, 2020, at 5:00 p.m. Eastern time to discuss its Q3 financial results for the period ending September 30, 2020. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which will include a Q&A session. Participants are encouraged to dial in 5-10 minutes early. The call will be available for replay after 8:00 p.m. Eastern time on the same day, until November 23, 2020.
Nature’s Sunshine operates in over 40 countries, providing high-quality herbal and nutritional products.
On October 16, 2020, qemp, backed by Nature's Sunshine, announced the expansion of its product line with qemp Calm and qemp Joint. These new offerings incorporate whole spectrum hemp extracts designed to support relaxation and joint health. qemp Calm utilizes a unique blend of Sceletium tortuosum and lemongrass for mood improvement, while qemp Joint combines essential oils like Indian frankincense and turmeric for enhanced mobility. Both products focus on activating the endocannabinoid system, ensuring effective results for daily use.
Nature's Sunshine Products (NASDAQ:NATR) will present at the 9th Annual Gateway Conference on September 10, 2020, at 7:30 a.m. Pacific time. The event will take place virtually from September 9-10, 2020, and will feature one-on-one meetings and live presentations. Attendees can access the presentation via webcast and request invitations for meetings by emailing conference@gatewayir.com. Nature's Sunshine is recognized for its high-quality nutritional and personal care products distributed across more than 40 countries.
Nature’s Sunshine Products (NASDAQ: NATR) has appointed Heidi Wissmiller to its board of directors, effective August 1, 2020. Wissmiller brings over 25 years of experience, having held senior management roles at Rodan + Fields, where she contributed to significant growth, achieving over $1 billion in sales. She also served as CEO at Micro Analytical Systems and held positions at PepsiCo and E & J Gallo Winery. Her expertise will aid Nature’s Sunshine’s transformation and global growth strategies.
Nature’s Sunshine Products, Inc. (NASDAQ: NATR) will hold a conference call on August 6, 2020, at 5:00 p.m. ET to discuss its Q2 financial results. The call will feature CEO Terrence Moorehead and CFO Joseph Baty, followed by a Q&A session. Interested parties can join by dialing a toll-free number or attending the live broadcast available for replay afterwards. Nature’s Sunshine, a leader in natural health products, manufactures its offerings in over 40 countries and aims for high quality, safety, and efficacy in its product line.